Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.029 SGD | -6.45% |
|
-6.45% | -35.56% |
Jul. 10 | IX Biopharma's Sublingual NAD+ Wafers Show Promising Results in Human Trial | MT |
Jun. 19 | Ix Biopharma Cuts Conversion Price of 9% Convertible Bonds | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.56% | 16.62M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- 42C Stock
- News iX Biopharma Ltd.
- IX Biopharma Ltd. Appoints Ms. Eva Tan as Its New Chief Commercial Officer